Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   IRANIAN JOURNAL OF NUCLEAR MEDICINE   2010 , Volume 18 , Number SUPPLEMENT 1; Page(s) 114 To 114.
 
Paper: 

SYNTHESIS AND BIODISTRIBUTION STUDY OF A CHLOROTOXIN DERIVATIVE PEPTIDE LABELED WITH IODINE-131 FOR TUMOR THERAPY

 
 
Author(s):  SHIRMARDI SEYED PEZHMAN*, SHAMSAEI MOJTABA, GANDOMKAR MOSTAFA, GHANNADI MARAGHEH MOHAMMAD
 
* NUCLEAR ENGINEERING AND PHYSICS, AMIRKABIR UNIVERSITY OF TECHNOLOGY, TEHRAN, IRAN
 
Abstract: 

Introduction: Chlorotoxin is a 36-amino acid peptide found in the venom of the Leiurus quinquestriatus which blocks small-conductance chloride channels. Chlorotoxin binds preferentially to glioma cells that allow development of new methods for the treatment and diagnosis of several types of cancer. Due to this a chlorotoxin derivative was labeled with 131I and investigated further.
Methods: A chlorotoxin derivative was synthesized on a solid phase using a standard Fmoc strategy. Labeling with iodine-131 was performed through chloramine-T method and radiochemical analysis involved sephadex G-25 and HPLC methods. The stability of radiopeptide was checked in the presence of PBS and human serum at 37oC up to 24 h. The biodistribution was studied in mice.
Results: The chemical purity of synthesized peptide as assessed by analytical RP-HPLC was 95%. Labeling of peptide resulted in a radiochemical yield of 80% with radiochemical purity of >95% with specific activity of 0.740 GBq/
mmol. Results of In vitro studies demonstrated acceptable stability of compound in human serum and PBS solution.
Conclusion: Biodistribution data showed moderate blood clearance, with concentration of radioactivity in the kidneys, liver, intestine and stomach.

 
Keyword(s): CANCER, PEPTIDE, 131I, LABELING, CHLOROTOXIN
 
References: 
  • ندارد
 
  Yearly Visit 63
 
Latest on Blog
Enter SID Blog